Agronomics Limited Blue Naln raises US$33.5m in Series B priced round (0507P)

TIDMANIC

RNS Number : 0507P

Agronomics Limited

09 October 2023

Agronomics Limited

("Agronomics" or the "Company")

Investee Company Update: BlueNalu Secures US$ 33.5 Million in Series B priced round

Agronomics, a leading listed company focused on the field of cellular agriculture, is pleased to announce that portfolio company BlueNalu, Inc. ("BlueNalu") has raised US$ 33.5 million from new and existing investors in a Series B Financing (the "Series B").

The financing will enable the next stage of BlueNalu's growth and its continued progress towards scaling and commericializing healthy and sustainable seafood in the U.S. and around the world. BlueNalu plans to launch its first commercial product, premium bluefin tuna toro, following regulatory approval.

Agronomics has invested, in aggregate, US$ 8 million across BlueNalu's Seed and Series A Financings and a pre-Series B Convertible Promissory Note ("CPN"). Following the close of the Series B, the CPN has been converted into Series B Preferred Shares. Agronomics now holds an equity stake in BlueNalu of 5.12% on a fully diluted basis. Subject to audit, Agronomics will now carry this position forward at a book value of GBP13.3m, an IRR of 26.85% and a MOIC of 2x.

The holding in BlueNalu will represent approximately 8% of the last published Net Asset Value of the Company (30.06.23), including estimated post-balance sheet date adjustments.

About Agronomics

Agronomics is the leading listed venture capital firm with a focus on cellular agriculture. The Company has established a portfolio of over 20 companies at the Pre-Seed to Series C stage in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population.

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.

Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists' claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5 .

AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however, less than US$ 5 billion has been invested worldwide since the industry's inception in 2016.

For further information please contact:

 
       Agronomics         Beaumont   Canaccord       Cavendish      Peterhouse              SEC Newgate 
         Limited           Cornish     Genuity       Securities       Capital 
                           Limited     Limited          Plc           Limited 
      The Company          Nomad    Joint Broker       Joint       Joint Broker          Public Relations 
                                                       Broker 
                        ==========  ============  =============  ===============  ============================= 
      Richard Reed         Roland      Andrew          Giles       Lucy Williams            Bob Huxford 
       Denham Eke          Cornish      Potts         Balleny         Charles              George Esmond 
                            James    Harry Rees       Michael        Goodfellow            Anthony Hughes 
                           Biddle    Alex Aylen       Johnson                                Alice Cho 
                                      (Head of 
                                      Equities) 
                        ==========  ============  =============  ===============  ============================= 
      +44 (0) 1624        +44 (0)     +44 (0)         +44 (0)         +44 (0) 
         639396            207 628     207 523        207 397         207 469 
   [e-mail]       3396        8000            8900            0936        [e-mail] 
                        ==========  ============  =============  ===============  ============================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEUPGMPUUPWGMR

(END) Dow Jones Newswires

October 09, 2023 02:00 ET (06:00 GMT)